BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2372276)

  • 1. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
    Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
    Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flucloxacillin-induced cholestatic liver damage.
    Bengtsson F; Florén CH; Hägerstrand I; Söderström C; Aberg T
    Scand J Infect Dis; 1985; 17(1):125-8. PubMed ID: 3992199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
    Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
    J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flucloxacillin-associated hepatic injury.
    Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
    Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.
    Victorino RM; Maria VA; Correia AP; de Moura C
    Arch Intern Med; 1987 May; 147(5):987-9. PubMed ID: 3579450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestatic hepatitis associated with flucloxacillin.
    Derby LE; Jick H; Henry DA; Dean AD
    Med J Aust; 1993 May; 158(9):596-600. PubMed ID: 8479374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged hepatic cholestasis after flucloxacillin therapy.
    Turner IB; Eckstein RP; Riley JW; Lunzer MR
    Med J Aust; 1989 Dec 4-18; 151(11-12):701-5. PubMed ID: 2593915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flucloxacillin and cholestatic hepatitis.
    Jick H; Derby LE; Dean AD; Henry DA
    Med J Aust; 1994 Apr; 160(8):525. PubMed ID: 8170433
    [No Abstract]   [Full Text] [Related]  

  • 10. Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.
    Eckstein RP; Dowsett JF; Lunzer MR
    Pathology; 1993 Jul; 25(3):223-8. PubMed ID: 8265236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flucloxacillin-associated liver damage.
    Lobatto S; Dijkmans BA; Mattie H; Van Hooff JP
    Neth J Med; 1982; 25(2):47-8. PubMed ID: 7070561
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholestatic jaundice due to derivatives of oxacillin.
    Deboever G
    Am J Gastroenterol; 1987 May; 82(5):483. PubMed ID: 3578231
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute Cholestatic Liver Injury From Hydralazine Intake.
    Harati H; Rahmani M; Taghizadeh S
    Am J Ther; 2016; 23(5):e1211-4. PubMed ID: 26291593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk of liver reactions after treatment with flucloxacillin].
    Lakartidningen; 1989 Mar; 86(11):977-8. PubMed ID: 2927200
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Zhao YL; Wang JB; Zhou GD; Shan LM; Xiao XH
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):463-9. PubMed ID: 19389047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701.
    Teixeira M; Macedo S; Batista T; Martins S; Correia A; Matos LC
    Rev Assoc Med Bras (1992); 2020; 66(1):12-17. PubMed ID: 32130375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetracycline-induced bile duct paucity and prolonged cholestasis.
    Hunt CM; Washington K
    Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestatic hepatitis after diagnostic ajmaline challenge.
    Hamoir C; Dano H; Komuta M; Druez P; Negrin Dastis S
    Acta Gastroenterol Belg; 2017; 80(3):425-426. PubMed ID: 29560676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH; Tsai SL; Chen TC; Liaw YF
    J Formos Med Assoc; 2000 Nov; 99(11):866-9. PubMed ID: 11155780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.